|
|
| Maladies Cardiovasculaires > Etude de marché sectorielle |
| Cardiovascular Catheters and Systems |
|
|
|
|
€ 3 012,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Octobre 2005 |
Taille du document : |
426 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 5 pages | Mai 2006 | Anglais
|
|
|
| Main
focus: |
cardiovascular catheters,cosmetic
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
|
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
161 pages | Octobre 2005 |
This report describes the specific market segment of the pharmaceutical market for diabetes and two of its related diseases, metabolic syndrome and cardiovascular disease.
It begins with a textbook |
2 800,00 €
|
| |
| |
Cardiovascular Catheters and Systems
426 pages | Octobre 2005 |
This report analyzes the worldwide markets for Cardiovascular Catheters and Systems in Millions of US$.
The major product segments analyzed are Diagnostic Catheters, and Therapeutic Catheters.
T |
3 012,00 €
|
| |
| |
The Emerging Drug Targets Outlook: An analysis of novel molecular targets to develop innovative new therapeutics
169 pages | Novembre 2005 |
Drug targets are generally proteins.
Nucleic acids are possible drug targets, and approaches such as RNA interference (RNAi) may indeed have advantages over proteins, but they have not so far been |
2 443,75 €
|
| |
| |
Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
71 pages | Octobre 2005 |
IntroductionThe increase in diabetic kidney disease is a worldwide problem.
Current treatment centers on antihypertensives inhibitors for the renin-angiotensin system and merely retards the decline |
3 230,00 €
|
| |
| |
Future Health Trends in Food and Drinks: Growth opportunities in daily dosing, GI, heart health, right fats and phood
196 pages | Août 2005 |
The GI diet is being driven due to rising obesity, rising diabetes and because the diet can be essentially seen as a sophistication of the Atkins diet; manufacturers are driving the trend by tailoring |
1 623,50 €
|
| |
| |
Computed Tomography Scanners
188 pages | Octobre 2005 |
This report analyzes the worldwide markets for Computed Tomography Scanners in Units.
The major product segments analyzed are Single Slice CT Scanners, Multi Slice CT Scanners, and Cardiac/EBT Scan |
2 699,00 €
|
| |
| |
Fitness Equipment
90 pages | Juillet 2002 |
This report will enable you to:
·Analyse the size of the UK market for fitness equipment, in value terms, 1997-2006
·Quantify the size of the UK market for commercial cardiovascu |
635,00 €
|
| |
| |
Innovation in Functional Food and Drinks: Growth opportunities from new nutraceutical ingredients
178 pages | Novembre 2005 |
Cardiovascular epidemiology data shows there will be increasing opportunities for cholesterol lowering products and functional health products with heart health benefits, particularly in the UK, Germa |
1 623,50 €
|
| |
| |
PharmaVitae 2005: Novo Nordisk Global and US Analysis
148 pages | Octobre 2005 |
IntroductionThis analysis examines the current position and future outlook for Novo Nordisk in the ethical pharmaceutical sector.
The profile encompasses global company strategy, portfolio and pipe |
4 845,00 €
|
| |
| |
Pipeline Insight: Antithrombotics - Anticoagulants and Antiplatelets Have Blockbuster Potential
383 pages | Octobre 2005 |
IntroductionDatamonitor estimates the total revenue generated from new antithrombotics in the seven major markets will reach approximately $10bn by 2015, with novel oral anticoagulants contributing ov |
9 690,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Cardiovascular Catheters and Systems |
|
|
This report analyzes the worldwide markets for Cardiovascular Catheters and Systems in Millions of US$. The major product segments analyzed are Diagnostic Catheters, and Therapeutic Catheters. The sub product segments analyzed include Angiography Catheters, EP Mapping Catheters, Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP RF Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 59 companies including many key and niche players worldwide such as Arrow International, Boston Scientific, C.R. Bard, Inc., Cardima, Inc., CryoCath Technologies, Inc., Edwards Lifesciences Corporation, EP Medsystems, Endocardial Solutions, Inc., Guidant Corporation, Johnson & Johnson, Cordis Corporation, Medtronic, Merit Medical Systems, Inc., St. Jude Medical, Endocardial Solutions, Inc., and Terumo Medical Corporation.
|
|
Cardiovascular Catheters and Systems
|
|
|
PPLSEN
|
|
|
|
|
